Bio-Rad Laboratories, Inc.
BIO
주식 순위
#2166
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
주가
$352.07
마지막 동기화: 2026-10-19
시가총액
$9.41B
변동 (1일)
-0.23%
변동 (1년)
9.37%
국가
US
거래 Bio-Rad Laboratories, Inc. (BIO)
카테고리
Healthcare
Bio-Rad Laboratories, Inc. (BIO)의 수익
Jun 2026 기준 수익 TTM: $350.40M
Bio-Rad Laboratories, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익은 $350.40M입니다. 2024년에 회사는 $-2.34B의 수익을 올렸으며 이는 2023년의 수익 $-850.10M과 감소입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Bio-Rad Laboratories, Inc.의 수익 기록 (2000 ~ 2026)
연말 수익
| 연도 | 수익 | 변화 |
|---|---|---|
| 2026 (TTM) | $350.40M | -64.80% |
| 2025 | $995.50M | -142.50% |
| 2024 | $-2.34B | 175.55% |
| 2023 | $-850.10M | -81.93% |
| 2022 | $-4.70B | -186.33% |
| 2021 | $5.45B | 10.80% |
| 2020 | $4.92B | 117.51% |
| 2019 | $2.26B | 345.66% |
| 2018 | $507.36M | 418.75% |
| 2017 | $97.81M | 135.33% |
| 2016 | $41.56M | -71.50% |
| 2015 | $145.85M | 10.86% |
| 2014 | $131.56M | 17.06% |
| 2013 | $112.39M | -51.47% |
| 2012 | $231.58M | -1.77% |
| 2011 | $235.76M | 7.03% |
| 2010 | $220.28M | 18.54% |
| 2009 | $185.83M | 30.10% |
| 2008 | $142.84M | 18.21% |
| 2007 | $120.84M | -14.92% |
| 2006 | $142.03M | 52.11% |
| 2005 | $93.37M | -4.06% |
| 2004 | $97.33M | -14.39% |
| 2003 | $113.69M | 8.89% |
| 2002 | $104.41M | 60.70% |
| 2001 | $64.97M | 42.97% |
| 2000 | $45.44M | 0.00% |
유사 기업 또는 경쟁사의 수익
| 회사 | 수익 | 수익 차이 | 국가 |
|---|---|---|---|
| $7.51B | 2,043.55% |
US
|
|
| $5.56B | 1,487.61% |
IE
|
|
| $5.15B | 1,369.18% |
US
|
|
| $3.86B | 1,001.88% |
US
|
|
| - | - |
DE
|
